Related Experiment Video
Updated: Apr 23, 2026
Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
Can side effects of steroid treatments be minimized by the temporal aspects of delivery method?
Georgina M Russell1, Stafford L Lightman
1University of Bristol, Henry Wellcome Laboratories for Integrative Neurosciences and Endocrinology , Dorothy Hodgkin Building, Whitson Street, Bristol, BS1 3NY , UK +44 0117 331 3123 ; +44 0117 331 3169 ; georgina.russell@bristol.ac.uk.
Introduction:
Glucocorticoids are commonly prescribed medications associated with significant mortality and morbidity, even when used at physiological dosages. The endogenous glucocorticoids are secreted in a complex rhythm consisting of both a daily circadian rhythm and a more rapid and dynamic ultradian rhythm that is highly conserved in nature. Current therapeutic options attempt to target the circadian aspects of this rhythm but do not take into account the oscillating ultradian pulsatility.
Areas Covered:
This article analyzes English-language literature on Pubmed and discusses the physiology and evidence behind the importance of different patterns of glucocorticoid presentation on gene regulation, animal responses and clinical significance.
Expert Opinion:
There is compelling evidence for pulsatility being an important factor in hypothalamic pituitary adrenal (HPA) axis regulation and tissue responses to glucocorticoids. Different patterns of gene regulation and neural and behavioral responses are seen dependent upon the pattern of glucocorticoid presentation. Disease states are associated with disordered HPA ultradian activity. Glucocorticoid treatments have significant risk/benefit issues. It is now time to go back to first principles and think about the physiology and patterns of drug presentation in glucocorticoid-based therapeutics.
More Related Videos
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
12:04Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
Published on: August 14, 2012
Related Concept Videos
01:22Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
01:23Ophthalmic Drug Delivery Systems
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...